PROMIS NEUROSCIENCES INC. Interest Expense
PROMIS NEUROSCIENCES INC. (PMN) reported Interest Expense of $76.78 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-05-12
- PROMIS NEUROSCIENCES INC. interest expense for the quarter ending 2024-09-30 was $1.00, a 100.00% decline year-over-year.
- PROMIS NEUROSCIENCES INC. interest expense for the quarter ending 2024-06-30 was -$1.00, a 100.00% decline year-over-year.
- PROMIS NEUROSCIENCES INC. interest expense for the quarter ending 2024-03-31 was $76.78K.
- PROMIS NEUROSCIENCES INC. interest expense for the quarter ending 2023-09-30 was $75.41K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $76.78K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $76.77K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $76.78K 10-Q · filed 2025-05-12 | ||
| 2023-09-30 | $75.41K 10-Q · filed 2024-11-14 | $124.59K derived: sum of 2 quarters · filed 2024-11-14 | $124.59K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $49.18K 10-Q · filed 2024-08-08 | $49.18K 10-Q · filed 2024-08-08 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $134.29K derived: sum of 2 quarters · filed 2022-11-14 | $282.06K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $134.29K 10-Q · filed 2022-08-12 | $282.06K 10-Q · filed 2022-08-12 | |
| 2021-09-30 | $140.91K 10-Q · filed 2022-11-14 | $274.60K derived: sum of 2 quarters · filed 2022-11-14 | $276.32K 10-Q · filed 2022-11-14 |
| 2021-06-30 | $133.69K 10-Q · filed 2022-08-12 | $135.41K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |